La cadena de opciones muestra datos clave de las opciones de acciones de Jiade a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Jiade..

Jiade (NASDAQ:JDZG) Bolsa, Cadena de Opciones

Jiade

Jiade Ltd specializes in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platform and auxiliary solutions. Auxiliary solutions encompass exam administration services and teaching support services throughout the entire teaching cycle. Specifically, the company offers pre-enrollment guidance on school/major selection and application strategy development, training for entrance exams, and assistance in the application process. The company also provides offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance included in the one-stop comprehensive education supporting services in the People's Republic of China.

ACTU

ALVO

BACK

CSBR

EVGR

GLRE

HEPA

JDZG

JYNT

LUNG

PRTA

SRRK

UNTY

VREX

YIBO

ZKIN

IMAC Holdings sube más del 108% tras anunciar Ignite Proteomics. Conoce las acciones más destacadas en la negociación previa.

Acciones de IMAC Holdings se disparan un 108%; 20 acciones en movimiento en el premercado de EE.UU.

Jiade Ltd

WIIM

VERV

Verve Therapeutics shares are trading higher after the company reported a year-over-year increase for Q1 EPS results.

ARCO

Arcos Dorados Holdings shares are trading lower after the company reported mixed Q1 financial results.

GRAL

GRAIL shares are trading lower after the company reported mixed Q1 financial results.

ZYNLONTA&#xAE;&nbsp;plus glofitamab (COLUMVI&#xAE;) demonstrated&nbsp;ORR of 95.5% and CR of 90.9%, among 22 evaluable patients with relapsed/refractory DLBCL
Safety and tolerability data were consistent with the known profiles of each agent
Updated data to be shared during poster presentation at EHA2025 on Saturday, June 14 at 12:30 p.m. ET and oral presentation at ICML on Friday, June 20 at 9:00 a.m. ET
LAUSANNE, Switzerland, May 14, 2025 /PRNewswire/ --&nbsp;ADC Therapeutics SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADCT#NYSE">ADCT</a>), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced data presentations from the LOTIS-7 Phase 1b clinical trial evaluating ZYNLONTA (loncastuximab tesirine-lpyl) in combination with glofitamab in patients with relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL). Updated results will be shared at the European Hematology Association 2025 Congress (EHA2025) taking place in Milan, Italy with an oral encore presentation at the 18th International Conference on Malignant Lymphoma (ICML) in Lugano, Switzerland. Updated LOTIS-5 safety run-in data evaluating the combination of ZYNLONTA plus rituximab (Lonca-R) will also be featured at EHA2025.

News

ADCT

ADC Therapeutics Presents Data From LOTIS-7 Phase 1B Clinical Trial Evaluating ZYNLONTA In Combination With Glofitamab In Patients With r/r DLBCL

Jefferies analyst Philippe Houchois downgrades Rivian Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) from Buy to Hold and maintains the price target from $16 to $16.

Downgrades

Price Target

Analyst Ratings

RIVN

Jefferies Downgrades Rivian Automotive to Hold, Maintains Price Target to $16

Contracts

Jacobs Was Selected As The Integrated Delivery Partner For Marinus Link, An Approximately 214 Mile (345-kilometer) Undersea And Underground High-voltage Direct Current (Hvdc) Electricity And Data Interconnector

Needham analyst Bernie McTernan reiterates Airbnb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>) from Hold to Hold.

Reiteration

ABNB

Needham Reiterates Hold on Airbnbto Hold

Jefferies analyst Ashley Helgans upgrades PVH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) from Hold to Buy and raises the price target from $70 to $105.

Upgrades

Jefferies Upgrades PVH to Buy, Raises Price Target to $105

Nissan Motor Co. Ltd. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NSANY#OTC">NSANY</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NSANF#OTC">NSANF</a>) announced major steps to reconfigure its global operations after a challenging financial year. The company said on Tuesday that it will slash thousands of jobs and close almost half of its production plants across the globe, as part of a multi-year restructuring plan targeted towards stabilizing its bottom line.
What Happened: The company shared plans to terminate nearly 15% of its workforce, which entails approximately 20,000 employees, by fiscal year 2027. This includes the 9,000 job cuts announced earlier. In addition, Nissan will also shrink its global manufacturing footprint, reducing the number of factories from 17 to 10 over two years.
Last week, reports emerged that the <a href="https://www.benzinga.com/news/25/05/45316137/nissan-scraps-11-billion-ev-battery-plant-eyes-cost-cuts-to-survive-report">company is canceling its plans</a> to establish a $1.1 billion electric vehicle battery factory in Kitakyushu, Japan.
See Also: <a href="https://www.benzinga.com/25/05/45250949/tech-layoffs-get-the-headlines-but-its-uncle-sam-doge-whos-bleeding-workers-in-2025">Intel, Meta Get The Headlines, But It&#8217;s Uncle Sam (DOGE) Who&#8217;s Bleeding Workers In 2025</a>
Why It Matters: Nissan faced a $4.5 billion loss in 2024, citing rising variable costs and ongoing global turmoil. "In the face of challenging FY24 performance and rising variable costs, compounded by an uncertain environment, we must prioritize self-improvement with greater urgency and speed," said CEO Ivan Espinosa. The company also noted it would prioritize U.S.-made products and move operations to <a href="https://www.benzinga.com/news/25/05/45316137/nissan-scraps-11-billion-ev-battery-plant-eyes-cost-cuts-to-survive-report">sidestep tariff-related pressures</a>.
"We are taking a prudent approach to reassess our targets and actively seek every possible opportunity to implement and ensure a robust recovery," Espinosa added.
Nissan was not the only major company to announce layoffs on Tuesday. Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) shared on the same day that it will cut <a href="https://www.benzinga.com/markets/equities/25/05/45398101/microsoft-to-cut-6000-jobs-in-global-restructuring-joins-meta-and-amazon-in-trimming-workforce-amid-ai-driven-shift">6,000 jobs worldwide</a>, amounting to about 3% of its total workforce.
Price Action: Nissan Motor stock closed at 354 JPY ($2.42) on the Tokyo Stock Exchange on Wednesday, down 0.70% for the day. Year to date, the stock has declined 25.44%.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/market-summary/25/05/45399940/warren-buffett-shows-how-patience-pays-98-of-his-160-billion-wealth-came-after-turning-65-thanks-the-power-of-compound-interest">Warren Buffett Shows How Patience Pays: 98% Of His $160 Billion Wealth Came After Turning 65, Thanks The Power Of &#8216;Compound Interest&#8217;</a></li>
</ul>
Image Via Shutterstock

Asia

Equities

Markets

Tech

General

MSFT

NSANF

NSANY

Nissan To Cut 20,000 Jobs, Shut 7 Plants Globally In Major Restructuring After $4.5 Billion Annual Loss

TSAT

Telesat And Arab Satellite Communications Organization Announced The Companies Have Successfully Negotiated And Signed A Term Sheet For A Multi-Gbps Capacity Pool Of Telesat Lightspeed Connectivity Services

Needham analyst Quinn Bolton reiterates Pixelworks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PXLW#NASDAQ">PXLW</a>) with a Buy and maintains $1.5 price target.

PXLW

Needham Reiterates Buy on Pixelworks, Maintains $1.5 Price Target

LAVA Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVTX#NASDAQ">LVTX</a>) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.38) by 65.79 percent. This is a 550 percent decrease over losses of $(0.02) per share from the same period last year.

Earnings

Earnings Beats

LVTX

LAVA Therapeutics Q1 EPS $(0.13) Beats $(0.38) Estimate

Needham analyst Mike Matson upgrades Establishment Labs Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESTA#NASDAQ">ESTA</a>) from Hold to Buy and announces $48 price target.

ESTA

Needham Upgrades Establishment Labs Hldgs to Buy, Announces $48 Price Target

Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) has surged 65% over the past month, sharply outperforming other digital assets after a prolonged stretch of <a href="https://www.benzinga.com/money/btc-vs-eth">underperformance relative to Bitcoin</a>.
What Happened: According to a new report by Bernstein on Wednesday, the rebound is being driven by a convergence of structural and tactical catalysts.
The rally, they argue, is underpinned by three primary trends: renewed focus on blockchain utility via stablecoins, rising institutional interest in Ethereum's Layer 2 ecosystems and a major unwind of bearish hedge fund positioning.
"Stablecoins are bringing back the focus on underlying blockchain networks becoming platform proxies to gain exposure to the growth trend," the report said. 
Ethereum currently accounts for 51% of minted stablecoin supply, making it a key infrastructure layer for this segment.
The second catalyst revolves around the Layer 2 chains built on Ethereum. 
"Layer 2 chains use ETH for gas fees as underlying currency, thus helping drive distribution and demand for ETH," Bernstein noted, pointing to Base's $85 million in annual sequencer fees and Robinhood's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) recent acquisition of WonderFi as indicators of broader adoption. 
Also Read: <a href="https://www.benzinga.com/markets/25/05/45388118/bitcoin-taps-105-000-heres-when-it-could-hit-122-000">Bitcoin Taps $105,000: Here&#8217;s When It Could Hit $122,000</a>
This model, Bernstein says, "might become the template for asset managers and institutional users launching their own layer 2 chain on Ethereum."
Lastly, the report highlights a more tactical reason for Ethereum's strength: a repositioning among crypto hedge funds. 
"For the last 12-18 months, ETH was the perfect delta-neutral hedge. Crypto hedge funds were long Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) and short ETH," the analysts wrote.
What&#8217;s Next: As the narrative now shifts toward blockchain utility and institutional adoption, these shorts are being closed.
The broader implication of Ethereum's rally is also positive for the digital asset ecosystem at large. 
"Resurgence of ETH and non-Bitcoin assets is also good for crypto exchanges and broker-dealers, as a broader crypto market rally reinvigorates retail traders," Bernstein said.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/05/45387228/can-the-us-china-tariff-de-escalation-send-bitcoin-ethereum-to-new-highs">Can The US-China Tariff De-Escalation Send Bitcoin, Ethereum To New Highs?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

$SOL

HOOD

3 Key Drivers Behind Ethereum's 65% Rally: Bernstein

Gain Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GANX#NASDAQ">GANX</a>) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.18) by 11.11 percent. This is a 27.27 percent increase over losses of $(0.22) per share from the same period last year.

GANX

Gain Therapeutics Q1 EPS $(0.16) Beats $(0.18) Estimate

Nexxen International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXN#NASDAQ">NEXN</a>) affirms FY2025 sales outlook from $380.00 million to $380.00 million vs $389.93 million estimate.

Guidance

NEXN

Nexxen International Affirms FY2025 Contribution ex-TAC of approximately $380 million

AFC Gamma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFCG#NASDAQ">AFCG</a>) reported quarterly earnings of $0.21 per share which missed the analyst consensus estimate of $0.25 by 16 percent. This is a 57.14 percent decrease over earnings of $0.49 per share from the same period last year.

Earnings Misses

AFCG

AFC Gamma Q1 Adj. EPS $0.21 Misses $0.25 Estimate

KRMN

Karman Holdings shares are trading higher after the company reported better-than-expected Q1 financial results.

CLBT

Cellebrite DI shares are trading lower after the company reported mixed Q1 financial results and cut its FY25 sales guidance with its midpoint below estimates. Also, the company issued Q2 sales guidance with its midpoint below estimates.

Arbutus Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABUS#NASDAQ">ABUS</a>) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.10) by 30 percent. This is a 30 percent decrease over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $1.76 million which missed the analyst consensus estimate of $1.78 million by 0.84 percent. This is a 15.14 percent increase over sales of $1.53 million the same period last year.

ABUS

Arbutus Biopharma Q1 EPS $(0.13) Misses $(0.10) Estimate, Sales $1.76M Miss $1.78M Estimate

Press Releases

JIADE LIMITED Announces Pricing of Initial Public Offering

JIADE LIMITED Announces Closing of $8 Million Initial Public Offering

WestPark Capital Announces Closing of $8 Million IPO for JIADE LIMITED (Nasdaq: JDZG)

JIADE LIMITED Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

ATA Creativity Global - American Depositary Shares, each representing two common shares

ATA Creativity Global

Color Star Technology Co., Ltd. - Class A Ordinary Shares

Color Star Tech

Ambow Education Holding Ltd. American Depository Shares (each representing twenty (20) Class A Ordinary Shares)

Ambow Education Holding

Amesite

Bright Scholar Education Holdings Limited American Depositary Shares, each representing four Class A Ordinary Share

Bright Scholar Education

Chegg

Skillful Craftsman Education Technology Limited - Ordinary Share

Skillful Craftsman

Four Seasons Education (Cayman) Inc. American Depositary Shares, each ADS representing 10 ordinary shares

Four Seasons Education

Genius Group

Golden Sun Health Technology Group Limited - Class A Ordinary Shares

Golden Sun Health Tech

Visionary Holdings

Jianzhi Education Technology Group Company Limited - American Depositary Shares

Jianzhi Education Tech

Classover Holdings, Inc. - Class B Common Stock

Classover Holdings

Legacy Education

Lixiang Education Holding Co., Ltd. - American Depositary Shares

Lixiang Education Hldg

Mynd.ai

Sunlands Technology Group American Depositary Shares, representing Class A ordinary shares

Comments

Jiade

Jiade (JDZG) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL